Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
03-Feb-2026 | 5,714 | 5,747 | 5,628 | 5,702.5 | 31,735 | 1,00,14,52,781 | 1,06,039 |
04-Feb-2026 | 5,678 | 5,728 | 5,635 | 5,653.5 | 13,199 | 44,68,31,949 | 48,740 |
05-Feb-2026 | 5,650.5 | 5,699 | 5,584.5 | 5,662.5 | 14,654 | 61,18,00,682 | 64,389 |
06-Feb-2026 | 5,683 | 5,706 | 5,569 | 5,684 | 13,054 | 29,76,63,629 | 25,532 |
09-Feb-2026 | 5,699.5 | 5,800 | 5,670 | 5,750.5 | 20,707 | 1,31,04,91,308.5 | 1,63,112 |
10-Feb-2026 | 5,750 | 5,833 | 5,733 | 5,811.5 | 20,415 | 48,96,44,870 | 49,877 |
11-Feb-2026 | 5,840 | 5,915 | 5,745 | 5,890 | 14,660 | 46,10,38,401.5 | 26,488 |
12-Feb-2026 | 5,894 | 5,906 | 5,810 | 5,870.5 | 12,477 | 41,04,18,180.5 | 27,026 |
13-Feb-2026 | 5,850 | 5,850 | 5,331.5 | 5,402.5 | 64,198 | 3,31,44,92,221.5 | 1,90,715 |
16-Feb-2026 | 5,431 | 5,537 | 5,364 | 5,480.5 | 24,490 | 72,84,79,228.5 | 26,421 |
17-Feb-2026 | 5,500 | 5,510 | 5,415.5 | 5,456.5 | 12,052 | 40,64,96,207.5 | 33,887 |
18-Feb-2026 | 5,460 | 5,483.5 | 5,401.5 | 5,464 | 13,232 | 45,53,91,580 | 39,299 |
19-Feb-2026 | 5,517 | 5,517 | 5,350.5 | 5,377 | 14,308 | 1,03,89,63,923.5 | 1,44,729 |
20-Feb-2026 | 5,330 | 5,401.5 | 5,328.5 | 5,392 | 10,020 | 35,82,88,594.5 | 39,468 |
23-Feb-2026 | 5,415 | 5,504 | 5,395.5 | 5,490.5 | 20,587 | 76,20,80,159 | 80,607 |
24-Feb-2026 | 5,500 | 5,508.5 | 5,448 | 5,495.5 | 17,779 | 65,48,07,506.5 | 83,503 |
25-Feb-2026 | 5,508.5 | 5,655 | 5,468 | 5,625 | 22,777 | 1,28,35,49,761.5 | 1,40,076 |
26-Feb-2026 | 5,635 | 5,764.5 | 5,622.5 | 5,752 | 15,769 | 48,10,30,555.5 | 25,055 |
27-Feb-2026 | 5,752 | 5,781.5 | 5,614 | 5,639.5 | 21,098 | 74,44,49,948.5 | 94,409 |
02-Mar-2026 | 5,415 | 5,619.5 | 5,415 | 5,566 | 12,170 | 30,01,43,006 | 23,981 |
04-Mar-2026 | 5,489.5 | 5,536 | 5,432 | 5,466.5 | 17,876 | 47,99,12,496.5 | 56,532 |
This inspection, conducted from March 10 through March 13, 2025, was to evaluate compliance with the legal standards concerning bioequivalence studies.
The company saw its revenues increase by 1.5% YoY at ₹3,374 crore from ₹3,324 crore.
The serum contains liposomal azelaic acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide.
R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.
According to sources, the floor price would be ₹5,616 per share, which is 3% lower than the current market price (CMP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
